Special populations

Older adults with schizophrenia: ageing with the illness

April 22, 2026 9 min read

For most of the twentieth century, growing old with schizophrenia was uncommon. Many people died young — from suicide, from cardiovascular disease, from the conditions of long-stay institutions. That picture has shifted. Better medications, deinstitutionalisation, and improvements in primary care have meant that more people with schizophrenia now reach their seventies and eighties than ever before. It is, on balance, good news. It also means a body of knowledge about ageing with the illness that the field is still catching up to.

In one sentence

Schizophrenia in older adults often looks different than it did at thirty — fewer florid symptoms, more cognitive concerns, more medical comorbidities — and the medication that worked at twenty-five may not be the right fit at sixty-five.

How symptoms evolve

The natural history of schizophrenia is more variable than older textbooks suggested. Long-term follow-up studies, including the well-known Vermont Longitudinal Study by Courtenay Harding, found that a substantial fraction of people with schizophrenia experience meaningful improvement decades into the illness — fewer positive symptoms, less hospital use, more stable functioning. This does not mean the illness disappears. It does mean a person at sixty-five often looks measurably different than the same person at twenty-five.

Common patterns in later life:

Medication in later life

Older bodies handle antipsychotics differently. Drug clearance slows. Sensitivity to side effects increases. Polypharmacy — being on multiple medications for multiple conditions — becomes the norm. A few principles guide thoughtful prescribing:

Lower doses, slower changes

Many older adults do well on doses substantially lower than they took at thirty. Tapering toward the minimum effective dose, slowly and with close monitoring for early warning signs, is often the right move.

Avoid the high-anticholinergic options when possible

Anticholinergic burden — the cumulative effect of medications that block acetylcholine — is associated with cognitive decline and falls. Olanzapine, clozapine, quetiapine, and chlorpromazine all carry meaningful anticholinergic effects. So do many of the medications used to manage EPS (benztropine, trihexyphenidyl). When clinically possible, lower-anticholinergic alternatives are preferred.

Watch the QT interval

Older patients are more vulnerable to QT prolongation. Periodic ECG monitoring is reasonable for higher-risk regimens (see QT prolongation).

Falls

Orthostatic hypotension, sedation, and parkinsonism all contribute to fall risk in older adults on antipsychotics. A fall in an older person with schizophrenia is not a minor event — hip fractures and head injuries can be life-changing.

Tardive dyskinesia after decades of treatment

Cumulative exposure is the strongest predictor of tardive dyskinesia, so older adults — particularly those who took first-generation antipsychotics for years — carry meaningful risk. The AAN guidelines on TD treatment now include valbenazine and deutetrabenazine as first-line options. See tardive dyskinesia explained.

Distinguishing schizophrenia from dementia

This is one of the harder questions in geriatric psychiatry. Some older adults with schizophrenia develop measurable cognitive decline that resembles a dementia process; some develop true comorbid Alzheimer's disease; some have stable lifelong cognitive impairment that is part of their schizophrenia rather than a new process. Neuropsychological testing, careful history, and imaging help, but uncertainty often persists.

Late-onset psychosis — first-episode psychosis appearing after age sixty — is a different question and warrants a thorough workup for delirium, medical illness, medication effects, and dementia, even when the symptoms look like schizophrenia. See late-onset schizophrenia.

Where people live

Housing is one of the central practical questions of later life with schizophrenia. Common arrangements include:

Nursing facilities vary widely in their comfort with residents who have psychotic disorders. Federal regulations restrict the use of antipsychotics in nursing homes for residents with dementia, but residents with primary schizophrenia retain access to their established regimens. Families should be prepared to advocate.

Caregivers — often the parents, increasingly the siblings

Many older adults with schizophrenia have been cared for by parents who are themselves now ageing or have died. Sibling caregivers, often adult children of the now-deceased parents, frequently inherit a complex care role with little preparation. The aging parent guide and sibling guide address parts of this dynamic.

Plan early

Special needs trusts, durable powers of attorney, and clear written care preferences are far easier to set up before a crisis. NAMI's local chapters can point families toward specialised attorneys; see nami.org.

End-of-life care

People with schizophrenia continue to die younger than the general population — by ten to twenty years on average, mostly from cardiovascular and respiratory disease. Palliative care services are underused in this population. A person with schizophrenia approaching the end of life deserves the same access to symptom-focused, dignity-preserving care as anyone else.

What good ageing looks like

The older adults with schizophrenia who do best tend to have a few things in common: a long-term relationship with at least one clinician, a settled housing situation, ongoing engagement with at least a small social world, attention to physical health, and, where possible, family or chosen family who stayed. None of this is automatic. All of it is achievable.


This article is for educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a qualified mental health professional. If you or someone you know is in crisis, call or text 988 in the US, or your local emergency number.

Frequently asked questions

Does schizophrenia 'burn out' with age?
Not exactly. Florid positive symptoms often become less prominent, but negative and cognitive symptoms tend to persist or worsen. The phrase 'burnout' has fallen out of favour because it suggests a complete recovery that is uncommon.
Should an older adult on long-standing antipsychotics try to come off them?
Maybe, but cautiously and with a prescriber's guidance. Tapering to the lowest effective dose can reduce side effect burden, but stopping completely carries a high relapse risk. See antipsychotic discontinuation.
Is it dementia or schizophrenia?
Sometimes both. Neuropsychological testing, brain imaging, and careful history help. The distinction matters because treatments differ — and because antipsychotic use in dementia carries specific FDA warnings.
Can older adults still benefit from CBTp or psychotherapy?
Yes. There is no upper age limit for CBT for psychosis or other evidence-based therapies. Adaptations may be needed for hearing, cognition, and pace.

Try Frida — your calm companion

Frida helps people living with schizophrenia track moods, manage medication, and build stability. 7-day free trial.

Get the app →